Page 22 - AN-1-3
P. 22

Advanced Neurology                                           Early inhibition of PDK1 prevents AD-like pathology




            A































            B                                                  C














            Figure 3. Diminished microgliosis in Pdk1 cKO/5×FAD mice. (A) Representative images of IHC for Iba1 in the cortex. Brain sections were prepared from
            control, Pdk1 cKO, 5×FAD, and Pdk1 cKO/5×FAD mice aged 2.5, 4, and 6 months. The immunoreactivity of Iba1 was qualitatively different between the
            control and 5×FAD mice. The scale bar is 20 μm. (B) Enlarged images for boxed regions in (A). The scale bar is 25 μm. (C) Quantification results showing
            the average number of Iba1+ cells in the cortex. There were significant differences in the number of Iba1+ cells between 5×FAD and Pdk1 cKO/5×FAD
            mice at 2.5 (*P < 0.05), 4 (***P < 0.001), and 6 (***P < 0.001) months (n = 3–4 mice per group per age).

              To study whether there are changes to astrocytes in   3.4. mTOR signaling is inhibited in 5×FAD mice with
            Pdk1 cKO/5×FAD mice, IHC was performed for GFAP.   PDK1 deficiency
            First, it was observed that GFAP immunoreactivity was   In the mTOR signaling pathway, S6 kinase (S6K)
            qualitatively higher in the Pdk1 cKO cortex and the 5×FAD   phosphorylates S6 at Ser235 and Ser236 (Ser235/236)
            cortex at 2.5, 4, and 6 months compared with the littermate   following its activation by mTOR [49,50] . We investigated
            controls (Figure 4A). GFAP immunoreactivity was reduced   whether this pathway is affected by PDK1 deletion. First,
            in the Pdk1 cKO/5×FAD cortex compared with the 5×FAD   we performed Western blotting for pS6 Ser235/236 . We found
            cortex  (Figure  4A  and  B).  Second,  the  total  number  of   that  the  levels  of  pS6 Ser235/236  were  significantly lower  in
            GFAP+ cells in the 5×FAD cortex at 4 or 6 months was   the  Pdk1  cKO/5×FAD  cortex  than  in  the  5×FAD  cortex
            more than that in the control cortex (Figure 4C; P < 0.001),   (Figure 5A and B). Second, we performed Western blotting
            but it was smaller in the Pdk1 cKO/5×FAD cortex than in   for phosphorylated 4E-BP1, an important member of the
            the 5×FAD cortex (Figure  4C;  P < 0.001). These results   mTOR pathway . We found that the levels of p4E-BP1 Ser65
                                                                           [51]
            suggest  that  astrogliosis  may  be  attenuated  by  PDK1   were lower in the Pdk1 cKO/5×FAD cortex compared with
            deletion in 5×FAD mice.                            5×FAD mice (Figure 5A and B). Third, we performed IHC


            Volume 1 Issue 3 (2022)                         6                       https://doi.org/10.36922/an.v1i3.153
   17   18   19   20   21   22   23   24   25   26   27